← Back to Search

Behavioural Intervention

Sugar-Sweetened Beverage Reduction Program for Diabetes

N/A
Recruiting
Led By Rodney Haring
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 18 years or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

Study Summary

This trial develops an educational program to reduce sugary drink consumption in Native American men, which can help reduce risk of chronic diseases like obesity, diabetes, and heart disease.

Who is the study for?
This trial is for Native American men aged 18 or older who are not living on tribal lands but are involved with Native organizations off-territory. They must own a smart device to receive study text messages.Check my eligibility
What is being tested?
The Indigenous SIPin program, which includes interviews, educational interventions, and discussions aimed at reducing sugar-sweetened beverage intake among participants to lower the risk of chronic diseases like diabetes and heart disease.See study design
What are the potential side effects?
Since this intervention involves education and lifestyle changes rather than medication, there are no direct medical side effects. However, participants may experience challenges in adjusting their diet.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in SSB intake for men affiliated with Native American athletic communities
Secondary outcome measures
Change in body weight
Sugar sweetened beverage intake

Trial Design

2Treatment groups
Experimental Treatment
Group I: Aim 2 - Indigenous SIPinExperimental Treatment1 Intervention
Participants receive the Indigenous SIPin intervention over 6 months, which includes in-person and/or virtual educational sessions weekly over 30 minutes for 12 weeks and text message communications BIW for 12 weeks and then monthly thereafter up to month 6.
Group II: Aim 1 - interview, focus groupExperimental Treatment2 Interventions
Participants complete interviews over 60 minutes and attend focus groups over 90 minutes in support of intervention adaptation and refinement
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Discussion
2021
N/A
~130

Find a Location

Who is running the clinical trial?

Roswell Park Cancer InstituteLead Sponsor
402 Previous Clinical Trials
31,007 Total Patients Enrolled
National Institute of Nursing Research (NINR)NIH
580 Previous Clinical Trials
10,376,461 Total Patients Enrolled
Rodney HaringPrincipal InvestigatorRoswell Park

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment still have available slots for participants?

"Based on the data hosted on clinicaltrials.gov, this experiment is currently looking for participants. The trial was originally advertised on August 1st 2021 and underwent its last edit twelve months ago, in September 2023."

Answered by AI

What is the aggregate figure of people partaking in this investigation?

"Affirmative. According to clinicaltrials.gov, this experiment is actively searching for volunteers. This research was first advertised on August 1st 2021 and the latest update was made September 12th 2023. The trial seeks 100 individuals from a single site of recruitment."

Answered by AI
~8 spots leftby Jul 2024